Biolinq Inc.
Clinical trials sponsored by Biolinq Inc., explained in plain language.
-
New patch could replace fingersticks for 5 days of glucose monitoring
Disease control CompletedThis study tested a small, wearable sensor that sits just under the skin and measures blood sugar continuously for up to 5 days in adults with diabetes. 247 participants wore the sensor along with a standard monitor and took fingerstick tests to compare accuracy. The goal was to …
Phase: NA • Sponsor: Biolinq Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New CGM put to the test: does tylenol throw it off?
Knowledge-focused CompletedThis study tested whether taking acetaminophen (like Tylenol) affects the accuracy of a new wearable continuous glucose monitor called the Biolinq System. Thirty-one adults with diabetes wore the device for three days and took fingerstick blood tests to compare readings. The goal…
Phase: NA • Sponsor: Biolinq Inc. • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:56 UTC